HIGHLIGHTS
SUMMARY
Accepted: 3 January 2023 Invasive fungal infections (IFIs) represent an important complication in patients hospitalized for COVID-19, especially severely ill ones during the middle and latter stages of the disease, being associated with a significant increase in mortality, morbidity and length of hospital stay. The main fungal pathogens reported in severe COVID-19 patients are Aspergillus spp. and Candida spp., followed by Mucorales, Pneumocystis jirovecii and other secondary IFIs usually diagnosed in severely immunocompromised patients (cryptococcosis, histoplasmosis, Coccidioides infections, Fusarium spp., and Scedosporium pulmonary infections). In detail, 6 patients developed candidemia; 7 patients . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.